ArticleVeterinary medicine (Auckland, N.Z.)2022
Seroprevalence and Associated Risk Factors of
Article in Veterinary medicine (Auckland, N.Z.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 9 citations in OpenAlex.
- PK/PD Modeling of a Novel Pleuromutilin Derivative Pleuro2-4 against Mycoplasma gallisepticum in Chicks.Journal of agricultural and food chemistry · 2026Article
- Pharmacokinetic/pharmacodynamic relationship of a novel pleuromutilin derivative APTM against Mycoplasma gallisepticum.Poultry science · 2026Article
- Detection of Chicken Respiratory Pathogens in Live Markets of Addis Ababa, Ethiopia, and Epidemiological Implications.Veterinary sciences · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Methods: A cross-sectional study was employed from January to September 2021 to estimate the seroprevalence and associated risk factors of MG in domestic layer chickens in large and small commercial poultry farms in Hawassa and Bishoftu area, Ethiopia. A total of 368 blood samples were collected. Data were analyzed using SPSS version-20, reported as percent prevalence, and Pearson's chi-square was used to assess the association between factors considered to have association with MG infection. The samples were processed by using an indirect ELISA (ProFLOKIBV, USA) test coated with antibody against MG. Results: The total seroprevalence of MG infection was found to be 70.65%. Significant variation in environmental risk factors with seroprevalence was assessed and the higher prevalence of MG was significantly ( Conclusion: The evidence from seroprevalence of the MG infection in the current finding provides an indication of the eminence of infection in the study areas. Moreover, it provides an insight on the prevalence of MG infection and further molecular characterization of the organism needs to be conducted in the areas. Biosecurity measures combined with vaccination and sero-monitoring should also be implemented in the farms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.